Should the Mood Disorder Questionnaire be used to diagnose bipolar disorder?

No. It may improve case finding, but diagnosis requires comprehensive clinical assessment, current mental-status examination, and longitudinal patient and collateral history. One cited study reported sensitivity of 66% and specificity of 86%.

Is lamotrigine appropriate for acute mania?

No. FDA labeling states that lamotrigine is not recommended for acute manic or mixed episodes and that acute mood-episode effectiveness has not been established. Its bipolar indication is maintenance treatment of bipolar I disorder after acute stabilization.

When should combination treatment be considered for mania?

A review of guideline recommendations suggests considering combination treatment after insufficient response following 1-2 weeks at therapeutic doses of a first-line antimanic agent, after dose optimization and assessment of adherence and substance use.

Bipolar Disorder — Astra MD

Q: What is the labeled quetiapine extended-release dose for adult bipolar depression?

The supplied FDA label specifies 50 mg/day on day 1, 100 mg/day on day 2, 200 mg/day on day 3, and 300 mg/day on day 4, then 300 mg/day.

Bipolar disorder requires longitudinal diagnostic assessment and phase-specific treatment. Prioritize recognition of past mania or hypomania in depressed patients, manage acute episodes with mood stabilizers or antipsychotics, and sustain relapse prevention through individualized maintenance medication, psychosocial care, and safety monitoring.

Diagnosis

Establish the longitudinal mood-episode diagnosis

Do not diagnose or exclude bipolar disorder from the current depressive presentation alone.

Diagnostic assessment should integrate the mental-status examination with a longitudinal account of mood episodes, including collateral history from family when available.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US In patients presenting with depression, actively seek prior manic or hypomanic episodes because unipolar depressive disorders are a common diagnostic misclassification.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US

Screening instruments can improve recognition but do not replace diagnostic assessment. The Mood Disorder Questionnaire is widely used; one tertiary mental-health study reported sensitivity of 66% (95% CI, 57%-73%) and specificity of 86%.ScienceDirectScienceDirectScreening for bipolar disorder in a tertiary mental health ... A positive screen should trigger a structured clinical history rather than establish the diagnosis.

Clarify episode polarity, severity, frequency, interepisode symptoms, prior treatments and responses, functional consequences, and associated risk.BMJBMJAssessment and management of bipolar disorder
Assess substance use, medication adherence, potential relapse triggers, early warning signs, and self-management strategies before attributing nonresponse to pharmacologic failure.BMJ+1BMJAssessment and management of bipolar disorder NatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview
Differentiate recurrent episodic mood change from affective instability associated with other conditions; this distinction has direct treatment implications.ScienceDirectScienceDirectDifferential diagnosis of bipolar affective disorder type II and borderline personality disorder: analysis of the affective dimension

High-yield diagnostic inputs and their practical use.BMJ+2BMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US BMJAssessment and management of bipolar disorder ScienceDirectScreening for bipolar disorder in a tertiary mental health ...
Input	Clinical use
Current mental-status examination	Characterize present mood state, psychosis, behavioral activation, impairment, and immediate risk as part of the diagnostic assessment.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment \| BMJ Best Practice US
Longitudinal patient and collateral history	Identify prior manic, hypomanic, depressive, or mixed episodes and establish illness course; include family input when available.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment \| BMJ Best Practice US
Mood Disorder Questionnaire	Use as a case-finding aid, not a diagnostic test; reported sensitivity was 66% and specificity 86% in one tertiary setting.ScienceDirectScienceDirectScreening for bipolar disorder in a tertiary mental health ...
Treatment and relapse history	Review prior response, adherence, episode severity and frequency, triggers, and early warning signs to guide treatment selection and relapse planning.BMJBMJAssessment and management of bipolar disorder

Acute treatment

Match treatment to episode polarity

Acute treatment choice should be driven by mania, depression, mixed features, severity, and prior response.

For acute mania, mood stabilizers and antipsychotics are core therapies, used as monotherapy or in combination.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US Antipsychotics are effective for acute mania, whereas their efficacy for depression varies by agent.The LancetThe LancetTreatment of bipolar disorder Lithium remains a first-line option for mania in many contemporary guidelines, either alone or in combination.NatureNatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview

For moderate or severe bipolar depression in a patient not receiving a bipolar medication, NICE-based guidance supports quetiapine monotherapy or fluoxetine combined with olanzapine.BMJBMJAssessment and management of bipolar disorder Quetiapine and olanzapine-fluoxetine combination have evidence for bipolar depression in systematic review evidence.Oxford AcademicOxford AcademicTreatment of bipolar disorder: a systematic review of available ... Traditional antidepressants alone are not indicated in bipolar disorder.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US

When a first-line antimanic agent at therapeutic dose has not produced sufficient response after 1-2 weeks, reassess dose optimization, adherence, and substance use before considering combination treatment.NatureNatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview This interval is guidance cited in a review of contemporary guideline recommendations rather than a patient-specific mandate.

Choose treatment with the anticipated maintenance strategy in view; acute stabilization is only one component of recurrent-illness care.BMJBMJMaintaining mood stability in bipolar disorder
For bipolar depression, monitor for emergent mania or hypomania and for worsening depressive symptoms during pharmacologic and psychological treatment.BMJBMJAssessment and management of bipolar disorder
Escalate care based on acute safety, behavioral disturbance, psychosis, inability to maintain self-care, and need for intensive monitoring; the supplied sources do not provide operational thresholds for site-of-care decisions.

Phase-specific pharmacologic options supported by the supplied evidence.accessdata fda+6accessdata fdaquetiapine fumarate extended-release tablets nctr-crs fdaThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. <br/> <br/> LAMOTRIGINE tablets, for oral use <br/> LAMOTRIGINE tablets for oral suspension <br/> Initial U.S. Approval: 1994 BMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US BMJAssessment and management of bipolar disorder The LancetTreatment of bipolar disorder NatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview Oxford AcademicTreatment of bipolar disorder: a systematic review of available ...
Clinical phase	Supported approach	Important limitation or tradeoff
Acute mania	Use a mood stabilizer or antipsychotic as monotherapy or in combination; lithium is a first-line option in many guidelines.BMJ+1BMJBipolar disorder in adults - Symptoms, diagnosis and treatment \| BMJ Best Practice US NatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview	Before adding therapy after inadequate response, address dose, adherence, and substance use.NatureNatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview
Bipolar depression	Quetiapine monotherapy or olanzapine-fluoxetine combination are supported options in cited guidance and review evidence.BMJ+1BMJAssessment and management of bipolar disorder Oxford AcademicTreatment of bipolar disorder: a systematic review of available ...	Antidepressant monotherapy is not indicated; monitor for mood switching or clinical deterioration.BMJ+1BMJBipolar disorder in adults - Symptoms, diagnosis and treatment \| BMJ Best Practice US BMJAssessment and management of bipolar disorder
Bipolar I maintenance	Consider ongoing medication after acute stabilization; quetiapine XR is labeled adjunctively with lithium or divalproex at 400-800 mg/day.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets	Periodically reassess need for maintenance therapy.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets
Lamotrigine use	Use for FDA-indicated maintenance treatment of bipolar I disorder to delay mood episodes after treatment of acute episodes with standard therapy.nctr-crs fdanctr-crs fdaThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. <br/> <br/> LAMOTRIGINE tablets, for oral use <br/> LAMOTRIGINE tablets for oral suspension <br/> Initial U.S. Approval: 1994	Do not use as treatment for acute manic or mixed episodes; acute mood-episode efficacy has not been established in the label.nctr-crs fdanctr-crs fdaThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. <br/> <br/> LAMOTRIGINE tablets, for oral use <br/> LAMOTRIGINE tablets for oral suspension <br/> Initial U.S. Approval: 1994

Quetiapine extended-release dosing in FDA labeling

For adults with bipolar depressive episodes, the extended-release quetiapine label specifies 50 mg/day on day 1, 100 mg/day on day 2, 200 mg/day on day 3, and 300 mg/day on day 4, followed by 300 mg/day.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets For adult bipolar I maintenance adjunctive to lithium or divalproex, labeled dosing is 400-800 mg/day.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets

In a 3-week placebo-controlled bipolar mania study of extended-release quetiapine, commonly observed adverse reactions occurring at least twice the placebo rate included somnolence (50% vs 12%), dry mouth (34% vs 7%), dizziness (10% vs 4%), constipation (10% vs 4%), and weight gain (7% vs 3%).accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets
The available FDA-label excerpt is from 2017; verify the current product-specific U.S. prescribing information before prescribing.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets

Long-term care

Treat relapse prevention as the central management objective

Maintenance planning should begin during acute stabilization and be revisited after every episode.

Bipolar disorder is recurrent; a cited review reports typical recurrence every 17-30 months, underscoring the need to reduce both manic and depressive relapse rather than merely terminate the index episode.BMJBMJMaintaining mood stability in bipolar disorder Long-term management should individualize medication, adjunctive psychosocial therapy, monitoring for treatment-emergent complications, and health behaviors including sleep hygiene, exercise, and stress management.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US

Lithium and valproate are both recommended monotherapies for relapse prevention in the source trial background.The LancetThe LancetLithium plus valproate combination therapy versus ... Lithium and quetiapine are described in a review of guideline evidence as agents with level 1 evidence for prevention of both manic and depressive episodes.NatureNatureExisting and emerging pharmacological approaches to the treatment of mania: A critical overview Selection should incorporate prior episode polarity, treatment response, adverse-effect burden, reproductive plans, comorbidity, and feasibility of monitoring.

Discuss the expected benefits and risks of long-term treatment, relapse after dose reduction or discontinuation, and the need to monitor mood and medication effects.BMJBMJAssessment and management of bipolar disorder
Review pregnancy intentions before medication changes; teratogenic concerns require treatment review in people planning pregnancy.BMJ+1BMJMaintaining mood stability in bipolar disorder BMJAssessment and management of bipolar disorder
Medication adverse effects may persist into maintenance and some clinically important toxicities emerge only with longer-term exposure; use agent-specific monitoring schedules.BMJBMJMaintaining mood stability in bipolar disorder
Offer a bipolar-specific psychological intervention with an evidence-based manual, or a high-intensity intervention such as cognitive behavioral therapy, interpersonal therapy, or behavioral couples therapy when appropriate.BMJBMJAssessment and management of bipolar disorder

Maintenance decisions that should be explicitly revisited.accessdata fda+3accessdata fdaquetiapine fumarate extended-release tablets nctr-crs fdaThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. <br/> <br/> LAMOTRIGINE tablets, for oral use <br/> LAMOTRIGINE tablets for oral suspension <br/> Initial U.S. Approval: 1994 BMJMaintaining mood stability in bipolar disorder BMJAssessment and management of bipolar disorder
Decision	Action
Need for ongoing therapy	Periodically reassess the need for maintenance treatment while accounting for recurrent illness course and prior relapse burden.accessdata fda+1accessdata fdaquetiapine fumarate extended-release tablets BMJMaintaining mood stability in bipolar disorder
Medication tolerability	Monitor medication-specific adverse effects and toxicity; some adverse effects persist and some become evident only with long-term treatment.BMJBMJMaintaining mood stability in bipolar disorder
Stopping or reducing therapy	Discuss relapse risk, expected benefits and harms, and monitor mood closely when treatment changes are contemplated.BMJBMJAssessment and management of bipolar disorder
Psychosocial relapse prevention	Use bipolar-specific or high-intensity psychological interventions alongside medication when clinically appropriate.BMJBMJAssessment and management of bipolar disorder

Prescribing cautions

Avoid polarity-treatment mismatches

The highest-value prescribing error is using an agent outside its evidence-supported role for the current phase.

Quetiapine has phase-specific labeled dosing and clinically meaningful sedating and metabolic adverse effects in trial data.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets Somnolence, dry mouth, dizziness, constipation, and weight gain should influence dose titration, counseling, fall-risk assessment, and follow-up planning.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets

Do not treat a positive bipolar screening result as confirmation; obtain a longitudinal episode history and collateral information when possible.BMJ+1BMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US ScienceDirectScreening for bipolar disorder in a tertiary mental health ...
Do not use traditional antidepressants alone for bipolar disorder.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US
Do not assume all antipsychotics have equivalent efficacy for bipolar depression; available evidence describes variable antidepressant efficacy across agents.The LancetThe LancetTreatment of bipolar disorder

Common treatment errors and corrective actions.accessdata fda+4accessdata fdaquetiapine fumarate extended-release tablets nctr-crs fdaThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. <br/> <br/> LAMOTRIGINE tablets, for oral use <br/> LAMOTRIGINE tablets for oral suspension <br/> Initial U.S. Approval: 1994 BMJBipolar disorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US The LancetTreatment of bipolar disorder ScienceDirectScreening for bipolar disorder in a tertiary mental health ...
Potential error	Corrective action
Labeling recurrent depression as unipolar without probing for prior activation	Obtain longitudinal patient and family history and use screening tools only as adjuncts to diagnostic assessment.BMJ+1BMJBipolar disorder in adults - Symptoms, diagnosis and treatment \| BMJ Best Practice US ScienceDirectScreening for bipolar disorder in a tertiary mental health ...
Using antidepressant monotherapy	Use a bipolar-specific pharmacologic strategy; traditional antidepressants alone are not indicated.BMJBMJBipolar disorder in adults - Symptoms, diagnosis and treatment \| BMJ Best Practice US
Using lamotrigine for acute mania	Select an antimanic treatment instead; lamotrigine is not recommended for acute manic or mixed episodes.nctr-crs fdanctr-crs fdaThese highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. <br/> <br/> LAMOTRIGINE tablets, for oral use <br/> LAMOTRIGINE tablets for oral suspension <br/> Initial U.S. Approval: 1994
Ignoring quetiapine adverse effects during titration	Anticipate somnolence, dry mouth, dizziness, constipation, and weight gain, and adjust monitoring and counseling accordingly.accessdata fdaaccessdata fdaquetiapine fumarate extended-release tablets

Bipolar Disorder